Diagnos Laboratorium Utama Tbk. (DGNS)
PT Diagnos Laboratorium Utama Tbk
Rp 162
4,00(2,53%)
CLOSED- Harga Pasar: Rp 162
- Volume Perdagangan: Rp 2.304.600
- Kapitalisasi Pasar: Rp 202.499.997.696
- Mata Uang: IDR
- Pasar: id_market
- Dividend Yield: -%
- Dividend Rate: Rp -
- Price to Book: 1,04
- Forward P/E: -
- Trailing P/E: 3,12
- EPS Tahun Ini: Rp 51,84
- EPS Perkiraan: Rp -
- Bid: Rp 162,00
- Ask: Rp 164,00
- Bid Size: -
- Ask Size: -
- Volume Rata-rata 10 Hari: 7.508.287
- Volume Rata-rata 3 Bulan: 9.580.466
- Book Value: Rp 155,53
- Fifty Day Average: Rp 158,58
- Two Hundred Day Average: Rp 204,90
- 52 Week Range: 121.0 - 380.0
- 52 Week High: Rp 380,00
- 52 Week Low: Rp 121,00
- Regular Market Open: Rp 158,00
- Regular Market Previous Close: Rp 158,00
- Regular Market Day High: Rp 167,00
- Regular Market Day Low: Rp 158,00
- Earnings Call Start: -
- Earnings Call End: -
- Earnings Timestamp: -
Sektor
Healthcare
Industri
Diagnostics & Research
Alamat Perusahaan
Gedung Graha Anam Lantai 2
Jl. Cikditiro No. 11 A, B, C Kelurahan Gondangdia Kecamatan Menteng
Jakarta Pusat
10350
Ringkasan Bisnis
PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers clinical pathology laboratory tests comprising hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology, microbiology, and anatomical pathology; and genomics laboratory tests that provides genetic testing for reproductive health, pregnant women, couples who want to have a child, oncology tests, drug sensitivity, DNAandMe, and others. It also offers homecare health services for hemoglobin, ferritin, retilulosit, hematologi rutin, SARS-COV-2 omicron screening molecular test, and PCR SARS-COV-2 H+1 B2C; and SARS-CoV-2 screening services. The company was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia.